You are here

Defence Therapeutics Inc.

Defence Therapeutics Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
DTC
CSE Index: 
Currency: 

Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.

You are here

Defence Therapeutics Inc. (DTC)

SEDAR Information

Company Info

Address
1680, 200 Burrard St.
Vancouver, BC V6C 3L6
Canada
Phone
514-947-2272
Email
sebas.plouffe@gmail.com
Website
https://defencetherapeutics.com
Listing date
Friday, May 7, 2021
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
34,798,774
Reserved for Issuance: 
11,996,400

Company Officers

Sébastien Plouffe, Chief Executive Officer
P. Joseph Meagher, Chief Financial Officer

Bulletins

06/05/2021

2021-0505 – New Listing - Defence Therapeutics Inc. (DTC)

Le 6 mai/May 2021

The common shares of Defence Therapeutics Inc., have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News